Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation

被引:48
作者
Johnson, Karen E. [1 ]
Knipe, David M. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
HSV-1; Innate immunity; Immune evasion; ICP27; Secreted protein; Type I interferon; TREATED HUMAN-CELLS; DOUBLE-STRANDED-RNA; POLY(A) SITE USAGE; MESSENGER-RNA; ALPHA-SUBUNIT; TRANSCRIPTIONAL ACTIVATOR; TYROSINE PHOSPHORYLATION; CYTOKINE SIGNALING-3; GAMMA(1)34.5 PROTEIN; REGULATORY FACTOR-3;
D O I
10.1016/j.virol.2009.09.021
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Host cells respond to viral infection by the production of type I interferons (IFNs), which induce the expression of antiviral genes. Herpes simplex virus I (HSV-1) encodes many mechanisms that inhibit the type I IFN response, including the ICP27-dependent inhibition of type I IFN signaling. Here we show inhibition of Stat-1 nuclear accumulation in cells that express ICP27. ICP27 expression also induces the secretion of a small, heat-stable type I IFN antagonizing protein that inhibits Stat-1 nuclear accumulation. We show that the inhibition of IFN-induced Stat-1 phosphorylation occurs at or upstream of Jak-1 phosphorylation. Finally, we show that ISG15 expression is induced after IFN alpha treatment in mock-infected cells, but not cells infected with WT HSV-1 or ICP27(-) HSV-1. These data suggest that HSV-1 has evolved multiple mechanisms to inhibit IFN signaling not only in infected cells, but also in neighboring cells, thereby allowing for increased viral replication and spread. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 81 条
[1]  
ALCAMI A, 1995, J VIROL, V69, P4633
[2]   INTERFERON INHIBITS HERPES-SIMPLEX VIRUS-SPECIFIC TRANSLATION - A REINVESTIGATION [J].
ALTINKILIC, B ;
BRANDNER, G .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :3107-3112
[3]   TRANSCRIPTIONAL INDUCTION BY DOUBLE-STRANDED-RNA IS MEDIATED BY INTERFERON-STIMULATED RESPONSE ELEMENTS WITHOUT ACTIVATION OF INTERFERON-STIMULATED GENE FACTOR-3 [J].
BANDYOPADHYAY, SK ;
LEONARD, GT ;
BANDYOPADHYAY, T ;
STARK, GR ;
SEN, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) :19624-19629
[4]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[5]  
Biron C.A., 2007, FIELDS VIROLOGY, V1, P249
[6]   HERPES-SIMPLEX VIRUS TRANSREGULATORY PROTEIN ICP27 STABILIZES AND BINDS TO 3'-ENDS OF LABILE MESSENGER-RNA [J].
BROWN, CR ;
NAKAMURA, MS ;
MOSCA, JD ;
HAYWARD, GS ;
STRAUS, SE ;
PERERA, LP .
JOURNAL OF VIROLOGY, 1995, 69 (11) :7187-7195
[7]   Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites [J].
Chee, AV ;
Roizman, B .
JOURNAL OF VIROLOGY, 2004, 78 (08) :4185-4196
[8]   ASSOCIATION OF A M(R)-90,000 PHOSPHOPROTEIN WITH PROTEIN-KINASE PKR IN CELLS EXHIBITING ENHANCED PHOSPHORYLATION OF TRANSLATION INITIATION-FACTOR EIF-2-ALPHA AND PREMATURE SHUTOFF OF PROTEIN-SYNTHESIS AFTER INFECTION WITH GAMMA(1)34.5(-) MUTANTS OF HERPES-SIMPLEX-VIRUS-1 [J].
CHOU, J ;
CHEN, JJ ;
GROSS, M ;
ROIZMAN, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10516-10520
[9]   Breaking new ground - are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? [J].
Clements, CJ ;
Abdool Karim, Q ;
Chang, ML ;
Nkowane, B ;
Esparza, J .
VACCINE, 2004, 22 (21-22) :2822-2826
[10]   VACCINIA VIRUS B18R GENE ENCODES A TYPE-I INTERFERON-BINDING PROTEIN THAT BLOCKS INTERFERON-ALPHA TRANSMEMBRANE SIGNALING [J].
COLAMONICI, OR ;
DOMANSKI, P ;
SWEITZER, SM ;
LARNER, A ;
BULLER, RML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (27) :15974-15978